53175 Bonn, de
+49 (228) 96568500
Start-up capital for a new kind of technology to manufacture printed circuit boards
High-Tech Gründerfonds, BayernKapital, Falk-Strascheg Holding and business angel have invested about EUR 750k in newly established Limata GmbH. The investment is intended to develop the technology and equipment further as well as to achieve market entry.
"Limata has made it possible with a patented device to substantially simplify the production of printed circuit boards for prototypes and small batches, and is thereby addressing a pressing demand from electronics manufacturers. The team has hitherto proven to be very strong on implementation and quickly established a pertinent network in the sector," says Dr Matthias Dill, investment manager at High-Tech Gründerfonds, who looks after the company as lead investor.
Limata's technology especially profitable
Customers benefit above all from cost reduction. Along with lower purchase costs, the manufacturers' production, maintenance and energy costs are cut by up to 75 percent. Circuit designers will shorten development periods by up to 5 days and get printed circuit boards of high precision - regardless of suppliers and their lead times. The device can be integrated in production immediately and offers the production company maximum flexibility with respect to the panel size and thickness to be processed. Furthermore, the machine can be operated directly from any workstation via the internal network.
With a 50 percent market share, Germany is the leading country in European printed circuit board production - this constitutes a sold foundation for successful entry into the market: "Ever since we started the development work we maintained close contact with PCB manufacturers in Germany, who visited us regularly as early as this development period. This enabled us to gear our product perfectly to the customer's requirements," says Matthias Nagel, technical director at Limata GmbH.
"In a time of economic crisis and sparse funding commitment, we are the first BMWi-EXISTsponsored company to have secured as many as four investors before the end of the oneyear funding period. That is a scenario we very much hoped for: from the outset we have key investors at our side who are familiar with our business model and might also support us in a further funding round with both capital and knowhow," adds Attila Heim, Limata GmbH's commercial director.
About Limata GmbH
Limata GmbH develops industrial precision machines for UV lithography of printed circuit boards. Limata is developing a new, innovative and costeffective process for this purpose. The device executes the process of structuring the printed circuit board by illuminating the photoresistcoated carrier material. The equipment is ideal for manufacturing rigid, semiflexible and flexible interconnect devices as used in all electronic components such as control systems. Limata GmbH is a spinoff from the "Limata" research project. The German Federal Ministry of Economics and Technology sponsored the startup team in 2009 within the framework of an EXIST seed programme.
About Bayern Kapital
Bayern Kapital was set up in 1995 as part of the Bavarian state government's "Bavarian Future Initiative" aimed at furnishing especially new, innovative Bavarian companies with venture capital. To date, Bayern Kapital has invested about EUR 152 million in more than 185 innovative, hightech companies. Bayern Kapital is available as a contact for businesses in the region and currently manages an overall fund volume of about EUR 214 million.
About Falk Strascheg Holding
The Falk Strascheg Holding is focused on the financing of young technology companies especially in the Seed and StartUp Phase. The young entrepreneurs receive not only risk capital but also advice based on entrepreneurial experience and financial knowhow. More information at www.extorel.de.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.